Bioline Rx Ltd ADR

BLRXNASDAQ · USD
1.30USD0.00 (-3.71%)
122

Bioline Rx Ltd ADR (BLRX) Option Chain

Read more

Tracking the BLRX option chain helps you see every strike and expiry on Bioline Rx Ltd ADR in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of BLRX options activity at a glance. Use our scanner to monitor the BLRX option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For BLRX stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where BLRX options are being actively traded, and where they are not.

BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials for the treatment of metastatic pancreatic adenocarcinoma patients, and Phase 1b clinical trials in patients with acute respiratory distress syndrome secondary to COVID-19 and other respiratory viral infections, as well as for the treatment of solid tumors and acute myeloid leukemia.

2026-11-20
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
100.003302.300.00—2.302.50+92.31—5.001.203.80000.00
100.0029600.800.00—0.805.00+284.621.206.003.70-0.10000.00
100.001405.000.00—5.007.50+476.923.708.506.20-0.10000.00

As of Nov 13, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV Rank2.38% Low
  • Market cap (M$)6
  • 52 weeks high-67.09%
  • 52 weeks low-3.70%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$22.00
    1592.31% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-23
  • P/E—
  • Future P/E—
  • EPS (ttm)-1.82
  • EPS growth next 5 years—

As of Nov 13, 2026